Inventor · disambiguated record
Vijay Potluri
Also filed as: POTLURI VIJAY · POTLURI VIJAY KUMAR
12 granted patents·4 pending applications·27 citations·filing 2006–2020
87Inventor score
Files withASANA BIOSCIENCES LLC9Dr Reddys Laboratories Ltd2POTLURI VIJAY KUMAR2FOUNDATION FOR NEGLECTED DISEASE RES1SASMAL PRADIP KUMAR1
Top patents by PatentIndex Score
16 records- 0186US9382277B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2014·Granted Jul 5, 2016·8 cites·28 claims
- 0282US8729079B2Pyrimido-pyridazinone compounds and methods of use thereofVENKATESAN ARANAPAKAM·Filed 2012·Granted May 20, 2014·8 cites·25 claims
- 0380US10647720B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2018·Granted May 12, 2020·1 cites·33 claims
- 0480US9499495B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2014·Granted Nov 22, 2016·4 cites·43 claims
- 0572US10183944B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2016·Granted Jan 22, 2019·1 cites·26 claims
- 0672US9487510B2Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonistsDr Reddys Laboratories Ltd·Filed 2013·Granted Nov 8, 2016·2 cites·30 claims
- 0772US2021113578A1Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathwaysASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 0870US10912779B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2019·Granted Feb 9, 2021·0 cites·23 claims
- 0968US8080668B2Thiazoles derivatives as AMPK activatorPOTLURI VIJAY KUMAR·Filed 2006·Granted Dec 20, 2011·3 cites·17 claims
- 1066US2020190095A1Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 1158US10226468B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2017·Granted Mar 12, 2019·0 cites·35 claims
- 1258US9757382B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2016·Granted Sep 12, 2017·0 cites·25 claims
- 1344US10131655B2Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonistsDr Reddys Laboratories Ltd·Filed 2016·Granted Nov 20, 2018·0 cites·9 claims
- 1443US2022401418A1Treatment of malaria using histone deacetylase (hdac) inhibitorsFOUNDATION FOR NEGLECTED DISEASE RES·Filed 2020·Application pending·0 cites
- 1538US2008221088A13,4-Substituted Thiazoles as Ampk ActivatorsPOTLURI VIJAY KUMAR·Filed 2006·Application pending·0 cites
- 1626US9303027B2Kappa opioid receptor agonistsSASMAL PRADIP KUMAR·Filed 2011·Granted Apr 5, 2016·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Vijay Potluri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →